Subscribe

medical-industry

by on

Chemotherapy administered in the last months of life -- which offers a boon to profit-seeking drug companies (one month's supply can cost $10,000 or more) -- significantly increased the odds that a cancer patient would require intensive treatment in the last week of life, late referral to hospice care, and death away from their preferred place, an investigation has shown.

TD originals

by on

The demise of the recent “death panels” debate was quick and painless -- unlike so many of the deaths that will occur among those who will now be without the benefit of their doctor’s knowledge of the dying process.The demise of “death panels” was quick and painless -- unlike so many deaths that will occur among those now without the benefit of their doctor's counsel.

Personalize your Truthdig experience. Choose authors to follow, bookmark your favorite articles and more.
Your Truthdig, your way. Access your favorite authors, articles and more.
or
or

A password will be e-mailed to you.

Statements and opinions expressed in articles and comments are those of the authors, not Truthdig. Truthdig takes no responsibility for such statements or opinions.